BSX Presentation At EuroPCR
At the EuroPCR conference, scheduled to be held between May 15 and 18 in Paris, Boston Scientific Corporation (NYSE:BSX) will be presenting data from several of its clinical programs. The company will be presenting data from the Evolve trial that evaluated the Synergy stent, the fourth-generation drug-eluting stent (“DES”). Boston Scientific is looking forward to [...]
At the EuroPCR conference, scheduled to be held between May 15 and 18 in Paris, Boston Scientific Corporation (NYSE:BSX) will be presenting data from several of its clinical programs.
The company will be presenting data from the Evolve trial that evaluated the Synergy stent, the fourth-generation drug-eluting stent (“DES”). Boston Scientific is looking forward to approval of the stent in Europe in late 2012 with its full launch scheduled for 2013. The company also has plans to begin trial of … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards